Drug-induced impulse control disorders in Parkinson's disease

Journal of Neurology

Volumn 258, Issue SUPPL. 2, 2011, Pages

  Reiff, J ^a   Jost, W H ^b  

^a HSK Wiesbaden ^*  (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Dopamine agonist; Impulse control disorders; Parkinson's disease; Ventral striatum

Indexed keywords

AMANTADINE; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR DISORDER; CONFERENCE PAPER; DEPRESSION; DISEASE CLASSIFICATION; DOPAMINE DYSREGULATION SYNDROME; HUMAN; IMPULSE CONTROL DISORDER; NEUROBIOLOGY; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL;

BRAIN; DOPAMINE; DOPAMINE AGONISTS; HUMANS; IMPULSE CONTROL DISORDERS; PARKINSON DISEASE;

EID: 79959947057     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-5932-1     Document Type: Conference Paper

References (49)

1. Antonini A, Cilia R (2009) Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf 32:475-488
2. American Psychiatric Association (2000) APA diagnostic and statistical manual of mental disorders, 4th edn text revision. American Psychiatric Association, Washington, DC
3. Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, Pelissolo A, Moro E, Lhommee E, Lang AE, Agid Y, Benabid AL, Pollak P, Mallet L, Krack P (2006) Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 21:1941-1946 (Pubitemid 44848942)
4. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2006) Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 21:2068-2072 (Pubitemid 46140413)
5. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2008) The thrill of reckless driving in patients with Parkinson's disease: an additional behavioural phenomenon in dopamine dysregulation syndrome? Parkinsonism Relat Disord 14:257-258 (Pubitemid 351458416)
6. Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (2009) Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 84:310-316
7. Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, Pezzoli G, Antonini A (2008) Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 65:1604-1611
8. Cools R, Barker RA, Sahakian BJ, Robbins TW (2003) L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41:1431-1441 (Pubitemid 36808816)
9. Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW (2007) L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 32:180-189 (Pubitemid 44967796)
10. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B (2002) Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 40:2257-2267 (Pubitemid 35303365)
11. Dagher A, Robbins TW (2009) Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 61:502-510
12. Dewey RB Jr (2010) Pathological gambling in PD: did the devil make me do it? Neurology 75:1668-1669
13. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377-1381 (Pubitemid 41352054)
14. Evans AH, Butzkueven H (2007) Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord 22:590-591 (Pubitemid 46608168)
15. Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65:1570-1574 (Pubitemid 41689470)
16. Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59:852-858 (Pubitemid 43673163)
17. Evans AH, Strafella AP, Weintraub D, Stacy M (2009) Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 24:1561-1570
18. Frank MJ, Seeberger LC, O'Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306:1940-1943 (Pubitemid 39627859)
19. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22:1757-1763 (Pubitemid 47597599)
20. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423-428 (Pubitemid 30248740)
21. Goerendt IK, Lawrence AD, Brooks DJ (2004) Reward processing in health and Parkinson's disease: neural organization and reorganization. Cereb Cortex 14:73-80 (Pubitemid 38018055)
22. Grace AA (2000) The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95(Suppl 2):S119-S128 (Pubitemid 30650376)
23. Grant JE, Levine L, Kim D, Potenza MN (2005) Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162:2184-2188 (Pubitemid 41598279)
24. Hariri AR, Brown SM, Williamson DE, Flory JD, de Wit H, Manuck SB (2006) Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci 26:13213-13217 (Pubitemid 46011631)
25. Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 23:411-415
26. Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403-1413 (Pubitemid 41105554)
27. Kunig G, Leenders KL, Martin-Solch C, Missimer J, Magyar S, Schultz W (2000) Reduced reward processing in the brains of parkinsonian patients. Neuroreport 11:3681-3687
28. Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A (2002) Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 27:1027-1035 (Pubitemid 35447639)
29. Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, Lees AJ, O'Sullivan DJ, Peppard RF, Rodrigues JP, Schrag A, Silberstein P, Tisch S, Evans AH (2009) Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 16:1148-1152
30. Lu C, Bharmal A, Suchowersky O (2006) Gambling and Parkinson disease. Arch Neurol 63:298
31. Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D (2008) Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 23:75-80 (Pubitemid 351281221)
32. O'Sullivan SS, Evans AH, Lees AJ (2009) Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 23:157-170
33. Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67:1258-1261 (Pubitemid 44563839)
34. Ray N, Strafella AP (2010) Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging. Clin EEG Neurosci 41:87-93
35. Rylander G (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75:203-212
36. Shaffer HJ, Hall MN, Vander Bilt J (1999) Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 89:1369-1376 (Pubitemid 29404561)
37. Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, Pezzoli G, Antonini A (2010) Cognitive status of patients with Parkinson's disease and pathological gambling. J Neurol 257:247-252
38. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C]raclopride PET study. Brain 132:1376-1385
39. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 68:400-404
40. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH (2007) Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68:301-303 (Pubitemid 46148346)
41. van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP (2010) Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75:1711-1716
42. Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ (2009) Psychotic and compulsive symptoms in Parkinson's disease. Mov Disord 24:738-744
43. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and rewardseeking behaviors in Parkinson disease. Neurology 67:1254-1257 (Pubitemid 44563838)
44. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212-216
45. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 24:1461-1467
46. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3, 090 patients. Arch Neurol 67:589-595
47. Wolters E, van der Werf YD, van den Heuvel OA (2008) Parkinson's disease-related disorders in the impulsive-compulsive spectrum. J Neurol 255(5):48-56
48. Wu K, Politis M, Piccini P (2009) Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J 85:590-596
49. Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:924-931